Meridian Bioscience (VIVO)
Meridian Bioscience Balance Sheet
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Assets | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Cash & Short Term Investments | 24.34M | 26.20M | 23.63M | 25.56M | 28.38M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Receivables | 27.75M | 24.02M | 24.84M | 23.99M | 25.40M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Inventory | 32.07M | 33.66M | 32.69M | 34.07M | 32.24M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Prepaid Expenses | 4.972M | 2.424M | 6.343M | 6.571M | 5.506M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Current Assets | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Current Assets | 92.21M | 89.41M | 90.35M | 92.52M | 93.82M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Gross Property, Plant & Equipment | 62.71M | 62.27M | 60.51M | 59.93M | 59.88M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Accumulated Depreciation | 36.11M | 35.64M | 33.97M | 33.47M | 35.07M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Net Property, Plant & Equipment | 26.60M | 26.63M | 26.54M | 26.46M | 24.81M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Long Term Investments | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Goodwill & Intangibles | 34.45M | 34.35M | 34.07M | 35.08M | 35.74M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Long Term Assets | 1.26M | 1.237M | 1.225M | 1.255M | 2.80M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Long Term Assets | 66.04M | 65.79M | 65.14M | 65.43M | 63.35M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Assets | 158.26M | 155.20M | 155.49M | 157.95M | 157.17M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Liabilities | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Current Portion of Long Term Debt | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Accounts Payable | 5.507M | 6.207M | 5.548M | 6.093M | 5.676M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Accrued Expenses | 4.743M | 4.035M | 4.235M | 4.10M | 4.313M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Deferred Revenues | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Current Liabilities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Current Liabilities | 16.32M | 16.56M | 15.26M | 17.18M | 16.97M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Long Term Debt | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Shareholder's Equity | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Deferred Income Tax | 1.172M | 0.933M | 1.705M | 2.649M | 2.614M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Long Term Liabilities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Long Term Liabilities | 1.172M | 0.933M | 1.705M | 2.649M | 2.614M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Liabilities | 17.49M | 17.49M | 16.97M | 19.83M | 19.58M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Common Shares Outstanding | 41.26M | 41.25M | 41.24M | 41.05M | 40.95M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Preferred Stock | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Common Stock, Net | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Additional Paid-in Capital | 101.53M | 101.10M | 100.01M | 97.58M | 96.36M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Retained Earnings | 38.66M | 36.84M | 38.06M | 39.11M | 40.01M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Treasury Stock | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Shareholder's Equity | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Shareholder's Equity | 140.77M | 137.70M | 138.52M | 138.12M | 137.59M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Liabilities & Shareholder's Equity | 158.26M | 155.20M | 155.49M | 157.95M | 157.17M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |